Yuki Nakanishi

12PUBLICATIONS
38CO-AUTHORS
NanomaterialsMolecular targetsCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 11, 2026
Natural product-based nanoengineering in gastrointestinal stromal tumors: early promise and translational challenges.

|Nov 23, 2025
Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer.

Kosuke Iwane, Yuki Nakanishi, Yu Muta

|Nov 16, 2024
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?

Munehiro Ikeda, Yuki Nakanishi, Hiroshi Seno

|Aug 28, 2024
Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning.

Munenori Kawai, Akihisa Fukuda, Ryo Otomo

|May 15, 2024
Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment.

Hideyuki Masui, Kenji Kawada, Yoshiro Itatani

|Dec 13, 2023
Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis.

Yu Muta, Juan F Linares, Anxo Martinez-Ordoñez

Pageof 2

Frequent Collaborators

3 joint publications

Maria T Diaz-Meco

3 joint publications

Hiroaki Kasashima

3 joint publications

Nobuyuki Kakiuchi

3 joint publications

Jorge Moscat